Overview

Liver Adiposity Effects on Pediatric Statin

Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
Single center, open-label, prospective investigation to quantify the effects hepatocellular fat has on hepatic statin transport and response in children and adolescents in obese and non-obese children and adolescents 8-21 years of age with normal, wild-type SLCO1B1 c.521TT genotype that are dosed rosuvastatin
Phase:
Phase 1
Details
Lead Sponsor:
Children's Mercy Hospital Kansas City
Treatments:
Rosuvastatin Calcium